Table 1 Patient characteristics for next-generation sequencing (NGS).
Patient | Gender | Age (years) | TNM stage | Pathological grade |
|---|---|---|---|---|
BCa1/NAT1 | Male | 56 | T2aN0M0 | Low |
BCa2/NAT2 | Male | 73 | T2bN1M0 | High |
BCa3/NAT3 | Female | 68 | T3aN1M0 | High |
BCa4/NAT4 | Male | 65 | T3bN1M1 | High |
BCa5/NAT5 | Male | 63 | T3aN1M1 | High |
LN(+)1 | Female | 58 | T3bN1M1 | High |
LN(+)2 | Male | 70 | T3bN1M1 | High |
LN(+)3 | Male | 66 | T3bN1M1 | High |
LN(+)4 | Male | 55 | T3bN1M1 | High |
LN(+)5 | Femle | 62 | T3AN1M0 | High |
LN(−)1 | Female | 56 | T3aN0M0 | High |
LN(−)2 | Male | 72 | T3bN0M0 | High |
LN(−)3 | Male | 63 | T2bN0M0 | High |
LN(−)4 | Male | 78 | T3bN0M0 | High |
LN(−)5 | Male | 64 | T3aN0M0 | High |
